Which category does Varenicline Tartrate belong to?

Varenicline Tartrate is classified as a smoking cessation agent. It works by targeting nicotine receptors in the brain to reduce withdrawal symptoms and cravings associated with quitting smoking. This pharmacological approach makes it effective for helping individuals to stop smoking by partially stimulating these receptors, which can mitigate the typical highs and lows experienced during nicotine withdrawal.

In contrast, the other categories listed do not apply to Varenicline. Weight management typically involves medications that help reduce body weight through various mechanisms, while anticonvulsants are used to control seizures in conditions such as epilepsy. Glaucoma agents are specifically aimed at reducing intraocular pressure in the eye. Therefore, the distinct function and purpose of Varenicline Tartrate firmly place it in the category of smoking cessation agents.